
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The role of osteopontin in the progression of solid organ tumour
Hailin Zhao, Qian Chen, Azeem Alam, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 299
Hailin Zhao, Qian Chen, Azeem Alam, et al.
Cell Death and Disease (2018) Vol. 9, Iss. 3
Open Access | Times Cited: 299
Showing 1-25 of 299 citing articles:
Pancreatic Tumor Microenvironment Factor Promotes Cancer Stemness via SPP1–CD44 Axis
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1998-2013.e7
Open Access | Times Cited: 171
Palanisamy Nallasamy, Rama Krishna Nimmakayala, Saswati Karmakar, et al.
Gastroenterology (2021) Vol. 161, Iss. 6, pp. 1998-2013.e7
Open Access | Times Cited: 171
Osteopontin as a multifaceted driver of bone metastasis and drug resistance
Xiaocong Pang, Kan Gong, Xiaodan Zhang, et al.
Pharmacological Research (2019) Vol. 144, pp. 235-244
Open Access | Times Cited: 157
Xiaocong Pang, Kan Gong, Xiaodan Zhang, et al.
Pharmacological Research (2019) Vol. 144, pp. 235-244
Open Access | Times Cited: 157
Advances in immunotherapy for triple-negative breast cancer
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 127
Yang Liu, Yueting Hu, Jinqi Xue, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 127
Biomineralization of Collagen-Based Materials for Hard Tissue Repair
Le Yu, Mei Wei
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 944-944
Open Access | Times Cited: 105
Le Yu, Mei Wei
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 944-944
Open Access | Times Cited: 105
Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib
Jung Woo Eun, Jung Hwan Yoon, Hye Ri Ahn, et al.
Cancer Communications (2023) Vol. 43, Iss. 4, pp. 455-479
Open Access | Times Cited: 84
Jung Woo Eun, Jung Hwan Yoon, Hye Ri Ahn, et al.
Cancer Communications (2023) Vol. 43, Iss. 4, pp. 455-479
Open Access | Times Cited: 84
The Significance of SPP1 in Lung Cancers and Its Impact as a Marker for Protumor Tumor-Associated Macrophages
Eri Matsubara, Hiromu Yano, Cheng Pan, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2250-2250
Open Access | Times Cited: 65
Eri Matsubara, Hiromu Yano, Cheng Pan, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2250-2250
Open Access | Times Cited: 65
Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics
Xing Jin, Huabao Cai, Zhiheng Lin, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 48
Xing Jin, Huabao Cai, Zhiheng Lin, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 48
Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Ali Doostmohammadi, Hossein Jooya, Kimia Ghorbanian, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Identification of immune suppressor candidates utilizing comparative transcriptional profiling in histiocytic sarcoma
Jennifer Lenz, Brandon Peng, Charles‐Antoine Assenmacher, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 3
Jennifer Lenz, Brandon Peng, Charles‐Antoine Assenmacher, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access | Times Cited: 3
Reverse Cardio‐Oncology: Cancer Development in Patients With Cardiovascular Disease
Joseph Pierre Aboumsallem, Javid J. Moslehi, Rudolf A. de Boer
Journal of the American Heart Association (2020) Vol. 9, Iss. 2
Open Access | Times Cited: 133
Joseph Pierre Aboumsallem, Javid J. Moslehi, Rudolf A. de Boer
Journal of the American Heart Association (2020) Vol. 9, Iss. 2
Open Access | Times Cited: 133
Mechanochemical Signaling of the Extracellular Matrix in Epithelial-Mesenchymal Transition
Lewis E. Scott, Seth H. Weinberg, Christopher A. Lemmon
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 118
Lewis E. Scott, Seth H. Weinberg, Christopher A. Lemmon
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 118
Low-Dose Anti-Angiogenic Therapy Sensitizes Breast Cancer to PD-1 Blockade
Qian Li, Yifan Wang, Weijuan Jia, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 7, pp. 1712-1724
Open Access | Times Cited: 117
Qian Li, Yifan Wang, Weijuan Jia, et al.
Clinical Cancer Research (2019) Vol. 26, Iss. 7, pp. 1712-1724
Open Access | Times Cited: 117
Targeting Cancer Associated Fibroblasts in Liver Fibrosis and Liver Cancer Using Nanocarriers
Leonard Kaps, Detlef Schuppan
Cells (2020) Vol. 9, Iss. 9, pp. 2027-2027
Open Access | Times Cited: 117
Leonard Kaps, Detlef Schuppan
Cells (2020) Vol. 9, Iss. 9, pp. 2027-2027
Open Access | Times Cited: 117
Altered perivascular fibroblast activity precedes ALS disease onset
Anna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 640-646
Open Access | Times Cited: 90
Anna Månberg, Nathan Skene, Folkert Sanders, et al.
Nature Medicine (2021) Vol. 27, Iss. 4, pp. 640-646
Open Access | Times Cited: 90
Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling
Jin Qian, Bauer L. LeSavage, Kelsea M. Hubka, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 16
Open Access | Times Cited: 88
Jin Qian, Bauer L. LeSavage, Kelsea M. Hubka, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 16
Open Access | Times Cited: 88
The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives
Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Jona Kadillari, et al.
Current Obesity Reports (2019) Vol. 8, Iss. 4, pp. 413-433
Closed Access | Times Cited: 84
Gerasimos Socrates Christodoulatos, Nikolaos Spyrou, Jona Kadillari, et al.
Current Obesity Reports (2019) Vol. 8, Iss. 4, pp. 413-433
Closed Access | Times Cited: 84
The Matrix Revolution: Matricellular Proteins and Restructuring of the Cancer Microenvironment
Casimiro Gerarduzzi, Ursula Hartmann, Andrew Leask, et al.
Cancer Research (2020) Vol. 80, Iss. 13, pp. 2705-2717
Closed Access | Times Cited: 84
Casimiro Gerarduzzi, Ursula Hartmann, Andrew Leask, et al.
Cancer Research (2020) Vol. 80, Iss. 13, pp. 2705-2717
Closed Access | Times Cited: 84
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer
Christina R Adams, Htet Htwe Htwe, Timothy Marsh, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 77
Christina R Adams, Htet Htwe Htwe, Timothy Marsh, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 77
Ran GTPase: A Key Player in Tumor Progression and Metastasis
Zied Boudhraa, Eurı́dice Carmona, Diane Provencher, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 77
Zied Boudhraa, Eurı́dice Carmona, Diane Provencher, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 77
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis
Erna Marija Meškytė, Sabiha Keskas, Yari Ciribilli
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7710-7710
Open Access | Times Cited: 75
Erna Marija Meškytė, Sabiha Keskas, Yari Ciribilli
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7710-7710
Open Access | Times Cited: 75
Upregulation of SPP1 Is a Marker for Poor Lung Cancer Prognosis and Contributes to Cancer Progression and Cisplatin Resistance
Huaping Tang, Jianyou Chen, Xiaolei Han, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 65
Huaping Tang, Jianyou Chen, Xiaolei Han, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 65
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
José D. Debes, Pablo A. Romagnoli, Jhon Prieto, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 64
José D. Debes, Pablo A. Romagnoli, Jhon Prieto, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 64
Hallmarks of aging-based dual-purpose disease and age-associated targets predicted using PandaOmics AI-powered discovery engine
Frank W. Pun, Geoffrey Ho Duen Leung, Hoi-Wing Leung, et al.
Aging (2022) Vol. 14, Iss. 6, pp. 2475-2506
Open Access | Times Cited: 54
Frank W. Pun, Geoffrey Ho Duen Leung, Hoi-Wing Leung, et al.
Aging (2022) Vol. 14, Iss. 6, pp. 2475-2506
Open Access | Times Cited: 54
The Role of Osteopontin in Tumor Progression Through Tumor-Associated Macrophages
Yuying Tan, Lei Zhao, Yong‐Guang Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 53
Yuying Tan, Lei Zhao, Yong‐Guang Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 53
The Role of Osteopontin in Microglia Biology: Current Concepts and Future Perspectives
Dennis-Dominik Rosmus, Clemens Lange, Franziska Ludwig, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 840-840
Open Access | Times Cited: 52
Dennis-Dominik Rosmus, Clemens Lange, Franziska Ludwig, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 840-840
Open Access | Times Cited: 52